BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 29, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Vaccine administration

Increase in side effects in mix-and-match vaccine schedule, study shows

May 12, 2021
By Nuala Moran
LONDON – Initial results from the U.K. randomized trial assessing mixed COVID-19 vaccine schedules show there is a significant increase in systemic side effects with one dose of Astrazeneca plc’s and one of Pfizer Inc./Biontech SE’s vaccines (in either order), compared to receiving two doses of the same vaccine.
Read More

Regulatory actions for May 12, 2021

May 12, 2021
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Applied DNA, Bioecho Life Sciences, Desktop Health, Chordate Medical, Endologix, Johnson & Johnson Vision, Qiagen.
Read More

Other news to note for May 12, 2021

May 12, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Burning Rock Biotech, Cyduct Diagnostics, E Ink, Ers Genomics, Flagship Biosciences, Fluorogenics, Fujifilm, Galaxy Medical, Genscript Biotech, Helio Health, Hhc Preferred, Japan Lifeline, Leap Therapeutics, Lucira, New England Biolabs, Novartis, Nuclera Nucleic, Pmb-Alcen, Sagentia Innovation, Sientra, Tilak Healthcare, Wearable Health Solutions.
Read More
Syringes in an apple

ACIP says yes to EUA expansion, caught off-guard by change in CDC guidance

May 12, 2021
By Mari Serebrov
It came as no surprise May 12 that the CDC’s Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one recusal, to recommend the use of Pfizer Inc.-Biontech SE’s COVID-19 vaccine, Comirnaty (tozinameran), in 12- to 15-year-olds following the FDA’s decision earlier this week to expand the vaccine’s emergency use authorization (EUA) to that age group.
Read More

Pandemic recovery key theme of Australia’s budget with med-tech, biotech sectors praising new measures

May 12, 2021
By Tamra Sami
PERTH, Australia – Australia’s budget theme for the 2021 to 2022 fiscal year is rebuilding the economy following COVID-19, and med-tech and biotech leaders were praising some of the new measures.  
Read More

Other news to note for May 12, 2021

May 12, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atai, Atyr, Azurrx, Biogen, Caladrius, Cassava, Cellectis, Diurnal, Citrine, ERS, Exelixis, Genfit, Genscript, Inovio, Intelgenx, Ipsen, Iqvia, Lianbio, Moderna, Nanobiotix, Protokinetix, Respirerx, Rubius, Sanofi, Voyager, Xilio.
Read More

In the clinic for May 12, 2021

May 12, 2021
Clinical updates, including trial initiations, enrollment status and data readouts and publications: ADC, Algernon, Amylyx, Biomarck, Biophytis, Cage, Checkpoint, Clene, Connect, Constant, Context, Graybug, GT, Incyte, Inflarx, Magenta, Medeor, Minerva, Morphosys, Ocuphire, Providence, Qpex, Scholar Rock, Ultimovacs, VBI.
Read More
COVID-19 vaccine vial on ice

U.S.-supported patent waiver meets with skepticism in Asia

May 11, 2021
By David Ho, Gina Lee, and Elise Mak
HONG KONG – The Biden administration’s support for a TRIPS waiver of COVID-19 vaccine patents has already met a chorus of resistance from Western companies. In Asia, skepticism about how it would be achieved and what it will cover, is widespread.
Read More

Pfizer: IP not the vaccine bottleneck

May 11, 2021
By Mari Serebrov
In an open letter to Pfizer Inc. employees, the company’s CEO, Albert Bourla, provided some insight about why some countries don’t have COVID-19 vaccines and others have a surplus. It has nothing to do with intellectual property (IP), or even price, Bourla said.
Read More

Other news to note for May 11, 2021

May 11, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: American Bionostica, Applied DNA Sciences, Biointellisense, Castle Biosciences, Cytosorbents, Doctor On Demand, Grand Rounds Health, Ott Scientific, Protech Home Medical, Quipt Home Medical, Speedx, Veemed.
Read More
Previous 1 2 … 236 237 238 239 240 241 242 243 244 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • Subsense BCI platform

    Next wave of BCI firms builds on pioneers to tackle challenges

    BioWorld
    With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
  • Boehringer Ingelheim identifies new mGlu3 receptor agonists

    BioWorld Science
    Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
  • GT-02897 exerts efficacy in preclinical multiple myeloma

    BioWorld Science
    Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing